Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Kidney Disease, Secondary Hyperparathyroidism”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00469599
What this trial is testing

Treatment of Secondary Hyperparathyroidism in the Uremic Patient

Who this might be right for
Secondary HyperparathyroidismChronic Kidney DiseaseVitamin D Deficiency
Zealand University Hospital 86
Not applicableStudy completedNCT00427037
What this trial is testing

Cholecalciferol (Vitamin D3) Therapy in Chronic Kidney Disease (CKD) Subjects

Who this might be right for
Chronic Kidney DiseaseVitamin D Deficiency
Atlanta VA Medical Center 34
Not applicableUnknownNCT03285854
What this trial is testing

Calcium Balance Studies in Children With CKD and on Dialysis

Who this might be right for
Chronic Kidney Disease Mineral and Bone Disorder
Great Ormond Street Hospital for Children NHS Foundation Trust 120
Not applicableUnknownNCT05549154
What this trial is testing

A Study on Prevention Strategies for CKD-SHPT and Related Complications Based on General Vitamin D Supplementation

Who this might be right for
Chronic Kidney Disease 5DSecondary Hyperparathyroidism Due to Renal CausesVitamin D Deficiency
First Affiliated Hospital Xi'an Jiaotong University 372
Large-scale testing (Phase 3)Study completedNCT02102204
What this trial is testing

Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis

Who this might be right for
Hyperparathyroidism, Secondary
Amgen 902
Large-scale testing (Phase 3)Study completedNCT00094484
What this trial is testing

Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis

Who this might be right for
Kidney DiseaseChronic Kidney Disease
Amgen 400
Large-scale testing (Phase 3)Study completedNCT01896232
What this trial is testing

Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease
Amgen 683
Post-approval studies (Phase 4)Study completedNCT00977080
What this trial is testing

Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D

Who this might be right for
Chronic Kidney DiseaseSecondary HyperparathyroidismHemodialysis
Abbott 272
Not applicableLooking for participantsNCT05242055
What this trial is testing

Integrated Diagnosis and Treatment of CKD on Outcomes

Who this might be right for
Chronic Kidney DiseasesHypertensionHyperglycemia+4 more
Capital Medical University 1,000
Not applicableLooking for participantsNCT06126016
What this trial is testing

A Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj.

Who this might be right for
Chronic Kidney Disease 5DSecondary Hyperparathyroidism
Boryung Pharmaceutical Co., Ltd 1,000
Not applicableNot Yet RecruitingNCT07820150
What this trial is testing

Hyperparathyroidism and Dialysis Adequacy in Hemodialysis Patients

Who this might be right for
Hyperparathyroidism, SecondaryKidney Failure, ChronicChronic Kidney Diseases
Assiut University 130
Not applicableStudy completedNCT01083849
What this trial is testing

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease (CKD) Patients With Paricalcitol in German and Austrian Clinical Practice

Who this might be right for
Kidney InsufficiencySecondary Hyperparathyroidism
AbbVie (prior sponsor, Abbott) 761
Post-approval studies (Phase 4)UnknownNCT05720273
What this trial is testing

Neutrophil Gelatinase-associated Lipocalin VS Vascular Calcification in Maintenance Hemodialysis Patients

Who this might be right for
Chronic Kidney Disease-Mineral and Bone Disorder
Xiaoyan Jia 80
Not applicableStudy completedNCT06314321
What this trial is testing

The Effect of Baduanjin on Shoulder Function in Maintenance Hemodialysis Patients

Who this might be right for
Hemodialysis ComplicationShoulder Joint DisorderCKD-MBD
Affiliated Hospital of Nantong University 60
Large-scale testing (Phase 3)Study completedNCT00042653
What this trial is testing

An Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on Dialysis

Who this might be right for
Secondary HyperparathyroidismEnd Stage Renal Disease
Amgen 380
Not applicableStudy completedNCT07212972
What this trial is testing

Mineral Bone Disorder in Dialysis

Who this might be right for
Chronic Kidney FailureChronic Kidney Disease-Mineral and Bone DisorderDialysis+1 more
Çanakkale Onsekiz Mart University 167
Not applicableUnknownNCT05350098
What this trial is testing

Efficacy of Plant-protein Diets in Patients With Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease Stage 5
Osaka University 40
Not applicableStudy completedNCT04013139
What this trial is testing

Relationship Between Cardiopulmonary Exercise Testing and Ca-P in Chronic Kidney Disease (CKD)

Who this might be right for
Ckd-Mbd
Shahid Beheshti University of Medical Sciences 200
Testing effectiveness (Phase 2)Study completedNCT01414114
What this trial is testing

Etelcalcetide to Treat Secondary Hyperparathyroidism in Hemodialysis Patients With Chronic Kidney Disease-Mineral and Bone Disorder

Who this might be right for
Secondary Hyperparathyroidism
KAI Pharmaceuticals 37
Testing effectiveness (Phase 2)Study completedNCT00742716
What this trial is testing

Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseSecondary HyperparathyroidismChronic Renal Insufficiency+1 more
OPKO IP Holdings II, Inc. 41
Next Page